title: Drug-induced lupus erythematosus.
abstract: Drug-induced lupus erythematosus (DILE) refers to a condition whose clinical, histological, and immunological features are similar to those seen in idiopathic lupus erythematosus but that occurs when certain drugs are taken and resolves after their withdrawal. Over 90 drugs have been linked to DILE to date and the list is growing. Like idiopathic lupus erythematosus, DILE has systemic, subacute cutaneous, and chronic cutaneous forms. A correct diagnosis is very important, as this condition usually resolves after withdrawal of the offending drug.
authors.affiliation: Departamento de Dermatología, Clínica Universidad de Navarra, Facultad de Medicina, Universidad de Navarra, Pamplona, España. Electronic address: mpretel@unav.es.
authors.forename: M
authors.initials: M
authors.lastname: Pretel
authors.affiliation: Departamento de Dermatología, Clínica Universidad de Navarra, Facultad de Medicina, Universidad de Navarra, Pamplona, España.
authors.forename: L
authors.initials: L
authors.lastname: Marquès
authors.affiliation: Departamento de Dermatología, Clínica Universidad de Navarra, Facultad de Medicina, Universidad de Navarra, Pamplona, España.
authors.forename: A
authors.initials: A
authors.lastname: España
mesh_terms: D015551:Autoimmunity; D001711:Biotransformation / Q000276:immunology; D057915:Drug Substitution; D064420:Drug-Related Side Effects and Adverse Reactions / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology; D004364:Pharmaceutical Preparations / Q000145:classification; D063189:Symptom Assessment
chemical_list: D004364:Pharmaceutical Preparations